about
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisIntrathecal Ziconotide and Morphine for Pain Relief: A Case Series of Eight Patients with Refractory Cancer Pain, Including Five Cases of Neuropathic Pain.Multiple Sclerosis in Pediatrics: Current Concepts and Treatment OptionsCurrent Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive ReviewMexazolam: clinical efficacy and tolerability in the treatment of anxietyFlorbetaben for PET Imaging of Beta-Amyloid Plaques in the BrainLaquinimod therapy in multiple sclerosis: a comprehensive reviewReview of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical AutoinjectorsCardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study.Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Change ObservedPrescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database StudyHigh-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study.Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial.Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study.Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS PatientsComparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims Database.Depression Among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in the Southwest Regional Hospitals of Cameroon: A Cross-Sectional Study.Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study.A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients.Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal NeurogenesisThe HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treatingPost hoc analysis of nutritional status in patients with transthyretin familial amyloid polyneuropathy: impact of tafamidis.Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.Listeria monocytogenes Meningoencephalitis Mimicking Stroke in a Patient with Chronic Lymphocytic Leukemia.Perampanel: What is its Place in the Management of Partial Onset Epilepsy?Social characteristics and quality of life of portuguese multiple sclerosis patients.Bilateral acute angle-closure glaucoma following treatment with topiramate for headache.A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers.Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study.Childhood absence epilepsy successfully treated with the paleolithic ketogenic diet.Effect of tetrabenazine on motor function in patients with huntington disease.A markov model approach assessing the cost of illness of generalized anxiety disorder in Canada.The impact of spina bifida on caregivers.Virtual reality versus conventional treatment of reaching ability in chronic stroke: clinical feasibility study.Latent Class Analysis to Classify Patients with Transthyretin Amyloidosis by Signs and Symptoms.Cost-Utility Analysis of Magnetic Resonance Imaging Management of Patients with Acute Ischemic Stroke in a Spanish Hospital.Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
P1433
Q26764754-4F6115F7-FABB-4475-8A22-EDCBAEE712D6Q27335738-3EA76853-748F-475C-8D63-C0565741B565Q28067298-1E4AD46B-6CAB-43D6-84F7-B0F6E4AD5354Q28079821-1F4FDBC4-0779-4451-9937-503B8C0EE16CQ28084954-97FFBEEA-E5FC-4EB5-9F75-58ADF6A1CE4BQ28085541-2CA8D6DC-3081-486B-842D-6CBC7A22F285Q28086844-DE7C7A72-C3F2-4C46-BB05-A67E6834E343Q30634431-3C32996C-EACD-446F-A981-97BE1A77B98CQ30830291-B1010FE8-9AB8-413B-9073-4DF4E8222734Q31130538-0D3B36DA-59BD-4BBB-93C4-6D7400E9760EQ33736183-678FD4A1-A8D9-4AFB-83F6-09B5EC3D6FE8Q33736188-CAFE4A1D-6A4F-4C44-B2D4-FC7BB3F566EFQ33736193-0DF5A2A9-EDF3-447B-A447-FDC85F1D2566Q33736198-F9B6597E-9958-474B-8556-1EDFFA627F4EQ33736204-A5DB54B5-DC1F-4A99-B1B5-5380B55F5F61Q33736209-950B383D-7A75-432D-A86B-D490916CD249Q33736215-7428BEF3-D57A-44C5-A48B-1356A49310ACQ33736221-423C4EBB-5CE3-4893-AA8D-FE25350AD1B4Q33736227-7DAEF10B-46CC-40D9-A06D-92FD78543BF9Q33736233-2658F3B8-259F-4C9B-827B-DEC678511FEBQ35240385-9EE97EAA-90BB-4EC1-A217-C3F33978B5E7Q35280640-3FE65257-1CD8-4D40-BB72-B5321CF395B0Q35280650-075F34D3-257B-4084-B53E-D73F65719422Q35280661-8D28B42D-D6E8-4009-9404-8A02306F9C67Q35280670-E485853C-B09B-44AC-AADD-39AF6AF8893FQ35280688-95B699AF-341E-4C1D-BF85-CD138E80C3F1Q35309217-B1B6D931-944F-471D-A0B1-11621B6515F0Q35309243-39E75E43-FD77-470E-9C9C-C5D26A44C34AQ35309265-6BC53752-30DB-4CF6-B828-99EDE8B92E3AQ35309277-7D570C80-8304-4FAE-93FE-A30BC52C8642Q35309295-6A7490E9-54AC-43CD-B1BD-2C3710FE81C3Q35309316-FE25CB69-6324-4EDD-A4B9-9277E5681EC7Q35309338-CEC4A1F5-91A5-44D4-88D8-53BE7937259BQ35309355-057FF0D8-F315-4A5F-A902-8A5FEB649DB1Q35309379-2EDD1DBD-E231-4182-AEE9-B9BDAC2110F1Q35309398-D4C06893-A3C0-4342-A531-456400736CC7Q35309422-F26516A9-07DF-4F96-8236-C79FA80DF8C0Q35752553-08F6C1EA-05A6-46B9-9BC2-813DE12AECC9Q35752556-BA7C940E-184C-4E42-BC18-1FE43F5C552AQ36389681-C18ACF7F-21FB-4DE6-8546-B7CA18D92C3D
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Adis, Springer Healthcare
@nl
wissenschaftliche Fachzeitschrift
@de
name
Neurology and therapy
@ast
Neurology and therapy
@en
Neurology and therapy
@es
Neurology and therapy
@it
Neurology and therapy
@nl
type
label
Neurology and therapy
@ast
Neurology and therapy
@en
Neurology and therapy
@es
Neurology and therapy
@it
Neurology and therapy
@nl
altLabel
Neurology and Therapy
@en
prefLabel
Neurology and therapy
@ast
Neurology and therapy
@en
Neurology and therapy
@es
Neurology and therapy
@it
Neurology and therapy
@nl
P31
P3181
P1055
P1156
21100466855